Skip to search formSkip to main contentSkip to account menu

fluperlapine

Known as: 3-fluoro-6-(4-methylpiperazinyl)-11H-dibenz(b,e)azepine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Antipsychotic AgentsDibenzazepines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Bioactivation of trimethoprim, fluperlapine and nevirapine, roles of iminoquinone-type Michael acceptors in idiosyncratic drug reactions
Idiosyncratic drug reactions are signifiant medical problems for both modem drug therapy and drug developrnent. Although iheir… 
1987
1987
Low-Dose Zotepine in the Maintenance Treatment of Schizophrenia
Zotepine is new tricyclic neuroleptic with a pharmacological profile comparable to substances such as thioridazine and… 
1986
1986
The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
1985
1985
Central antiserotonin action of fluperlapine.
The effect of fluperlapine--a new nonclassical neuroleptic--on the central serotoninergic system was studied. Fluperlapine… 
1984
1984
Antipsychotic Efficacy of Fluperlapine
In an open multicenter trial 46 schizophrenic patients were treated with fluperlapine for 20 days. A mean daily dosage of 300–400… 
1984
1984
Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
In an open multicenter trial (7 hospitals) 85 schizophrenic patients were treated with 3-fluoro-6-(4-methyl-piperazinyl)- 11H… 
1984
1984
FLUPERLAPINE: PHARMACOLOGIC PROPERTIES AND CLINICAL EFFECTS